Dejka M. Araujo, M.D.

Peer-Reviewed Articles

1. Wermke M, Araurjo DM, Chatterjee M, Tsimberidou AM, W Holderried TA, Jazaeri AA, Reshef R, Bokemeyer C, Alsdorf W, Wetzko K, Brossart P, Aslan K, Backert L, Bunk S, Fritsche J, Gulde S, Hengler S, Hilf N, Hossain MB, Hukelmann J, Kalra M, Krishna D, Kursunel M, Maurer D, Mayer-Mokler A, Mendrzyk R, Mohamed A, Pozo K, Satelli A, Letizia M, Schuster H, Schoor O, Wagner C, Rammensee H, Reinhardt C, Singh-Jasuja H, Walter S, Weinschenk T, Luke JJ, Britten CM. Autologous T-cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial. Nature Medicine, 2025. e-Pub 2025.
2. Patel RR, Delclos GL, DeSantis SM, Cannell MB, Lupo PJ, Bishop AJ, Lazar AJ, Lin PP, Benjamin RS, Patel SR, Ludwig J, Ravi V, Livingston JA, Somaiah N, Zarzour MA, Conley AP, Araujo DM. Does the Primary Tumor Site Drive Biology for Patients With Synovial Sarcoma?. Am J Clin Oncol 48(1):21-27, 2025. e-Pub 2025. PMID: 39224003.
3. Patel RR, Gopalakrishnan V, Amini B, Lazar AJ, Lin PP, Benjamin RS, Bishop AJ, Goepfert RP, Araujo DM. Oncologic Outcomes in Patients with Localized, Primary Head and Neck Synovial Sarcoma. Cancers (Basel) 16(23), 2024. e-Pub 2024. PMID: 39682304.
4. Pal, K, Awad, AA, Yevich, SM, Kuban, JD, Tarn, AL, Huang, SY, Odisio, BC, Gupta, S, Habibollahi, P, Bishop, AJ, Conley, AP, Somaiah, N, Araujo, DM, Zarzour, MA, Ravin, R, Roland, CL, Keung, EZ, Sheth, RA. Safety and Efficacy of Percutaneous Cryoablation for Recurrent or Metastatic Soft-Tissue Sarcoma in Adult Patients. American Journal of Roentgenology 223(4), 2024. e-Pub 2024. PMID: 39082849.
5. Patel RR, Delclos GL, DeSantis SM, Cannell MB, Lupo PJ, Lin PP, Araujo DM. Epidemiological trends of synovial sarcoma by primary tumor sites in the US from 2000 to 2020. Cancer Epidemiol 92:102627, 2024. e-Pub 2024. PMID: 39048411.
6. Yoder AK, Farooqi A, Mitra D, Livingston JA, Araujo DM, Sturgis EM, Goepfert R, Bishop AJ, Guadagnolo BA. Outcomes for Patients With Head and Neck Sarcoma Treated Curatively With Radiation Therapy and Surgery. Pract Radiat Oncol 14(5):e373-e382, 2024. e-Pub 2024. PMID: 38851534.
7. Awad A, Pal K, Yevich S, Kuban JD, Tam A, Odisio BC, Gupta S, Habibollahi P, Bishop AJ, Conley AP, Somaiah N, Araujo DM, Zarzour MA, Ratan R, Roland CL, Keung EZ, Huang SY, Sheth RA. Safety and efficacy of percutaneous image-guided ablation for soft tissue sarcoma metastases to the liver. Cancer 130(15):2703-2712, 2024. e-Pub 2024. PMID: 38642369.
8. Nasr LF, Zoghbi M, Lazcano R, Nakazawa M, Bishop AJ, Farooqi A, Mitra D, Guadagnolo BA, Benjamin R, Patel S, Ravi V, Araujo DM, Livingston A, Zarzour MA, Conley AP, Ratan R, Somaiah N, Lazar AJ, Roland C, Keung EZ, Nassif Haddad EF. High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center Experience. Cancers (Basel) 16(9), 2024. e-Pub 2024. PMID: 38730715.
9. Denu RA, Joseph CP, Urquiola ES, Byrd PS, Yang RK, Ratan R, Zarzour MA, Conley AP, Araujo DM, Ravi V, Nassif Haddad EF, Nakazawa MS, Patel S, Wang WL, Lazar AJ, Somaiah N. Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal Tumors. Cancers (Basel) 16(9), 2024. e-Pub 2024. PMID: 38730662.
10. D'Angelo SP, Araujo DM, Abdul Razak AR, Agulnik M, Attia S, Blay JY, Carrasco Garcia I, Charlson JA, Choy E, Demetri GD, Druta M, Forcade E, Ganjoo KN, Glod J, Keedy VL, Le Cesne A, Liebner DA, Moreno V, Pollack SM, Schuetze SM, Schwartz GK, Strauss SJ, Tap WD, Thistlethwaite F, Valverde Morales CM, Wagner MJ, Wilky BA, McAlpine C, Hudson L, Navenot JM, Wang T, Bai J, Rafail S, Wang R, Sun A, Fernandes L, Van Winkle E, Elefant E, Lunt C, Norry E, Williams D, Biswas S, Van Tine BA. Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial. Lancet 403(10435):1460-1471, 2024. e-Pub 2024. PMID: 38554725.
11. Farooqi AS, Yoder AK, Lin HY, Pasalic D, Erasmus J, Betancourt S, Wernz C, Mitra D, Zarzour MA, Somaiah N, Conley A, Ratan R, Livingston A, Araujo DM, Roland C, Scally C, Keung E, Gandhi SN, Ashleigh Guadagnolo B, Nguyen QN, Bishop AJ. SABR for Sarcoma Lung Metastases: Indications for Treatment and Guidance for Patient Selection. Int J Radiat Oncol Biol Phys 118(4):971-978, 2024. e-Pub 2024. PMID: 37914142.
12. Thirasastr, P, Sutton, TL, Joseph, CP, Lin, Y, Amini, B, Mayo, SC, Araujo, DM, Benjamin, RS, Conley, AP, Livingston, JA, Ludwig, JA, Patel, S, Ratan, R, Ravi, V, Zarzour, MA, Nassif Haddad, EF, Nakazawa, MS, Zhou, X, Heinrich, MC, Somaiah, N. Outcomes of Late-Line Systemic Treatment in GIST. Cancers 16(5), 2024. e-Pub 2024. PMID: 38473266.
13. Roland CL, Nassif Haddad EF, Keung EZ, Wang W, Lazar AJ, Lin H, Chelvanambi M, Parra ER, Wani K, Guadagnolo B, Bishop AJ, Burton EM, Hunt KK, Torres KE, Feig BW, Scally CP, Lewis VO, Bird JE, Ratan R, Araujo D, Zarzour M, Patel S, Benjamin R, Conley AP, Livingston J, Ravi V, Tawbi HA, Lin PP, Moon BS, Satcher RL, Mujtaba B, Witt RG, Traweek RS, Cope B, Lazcano R, Wu C, Zhou X, Mohammad MM, Chu RA, Zhang J, Damania A, Sahasrabhojane P, Tate T, Callahan K, Nguyen S, Ingram D, Morey R, Crosby S, Mathew G, Duncan S, Lima CF, Blay J, Fridman WH, Shaw K, Wistuba I, Futreal A, Ajami N, Wargo JA, Somaiah N. A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. Nature Cancer, 2024. e-Pub 2024.
14. Nakazawa MS, Livingston JA, Zarzour MA, Bishop AJ, Ratan R, Ludwig JA, Araujo DM, Somaiah N, Ravi V, Nassif EF, Roland CL, Lazar AJ, Guadagnolo BA, Harrison DJ, Benjamin RS, Patel SR, Conley AP. Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohort. Rare Tumors 16:20363613241271669, 2024. e-Pub 2024. PMID: 39105190.
15. Thirasastr P, Lin H, Amini B, Wang WL, Cloutier JM, Nassif EF, Keung EZ, Roland CL, Feig B, Araujo D, Benjamin RS, Conley AP, Livingston JA, Ludwig J, Patel S, Ratan R, Ravi V, Zarzour MA, Zhou X, Somaiah N. Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcoma. Cancer Med 12(4):4282-4293, 2023. e-Pub 2023. PMID: 36151848.
16. Hong DS, Van Tine BA, Biswas S, McAlpine C, Johnson ML, Olszanski AJ, Clarke JM, Araujo D, Blumenschein GR, Kebriaei P, Lin Q, Tipping AJ, Sanderson JP, Wang R, Trivedi T, Annareddy T, Bai J, Rafail S, Sun A, Fernandes L, Navenot JM, Bushman FD, Everett JK, Karadeniz D, Broad R, Isabelle M, Naidoo R, Bath N, Betts G, Wolchinsky Z, Batrakou DG, Van Winkle E, Elefant E, Ghobadi A, Cashen A, Grand'Maison A, McCarthy P, Fracasso PM, Norry E, Williams D, Druta M, Liebner DA, Odunsi K, Butler MO. Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial. Nat Med 29(1):104-114, 2023. e-Pub 2023. PMID: 36624315.
17. Gyurdieva A, Zajic S, Chang YF, Houseman EA, Zhong S, Kim J, Nathenson M, Faitg T, Woessner M, Turner DC, Hasan AN, Glod J, Kaplan RN, D'Angelo SP, Araujo DM, Chow WA, Druta M, Demetri GD, Van Tine BA, Grupp SA, Fine GD, Eleftheriadou I. Biomarker correlates with response to NY-ESO-1 TCR T cells in patients with synovial sarcoma. Nat Commun 13(1):5296, 2022. e-Pub 2022. PMID: 36075914.
18. Lazcano R, Barreto CM, Salazar R, Carapeto F, Traweek RS, Leung CH, Gite S, Mehta J, Ingram DR, Wani KM, Vu KT, Parra ER, Lu W, Zhou J, Witt RG, Cope B, Thirasastr P, Lin HY, Scally CP, Conley AP, Ratan R, Livingston JA, Zarzour AM, Ludwig J, Araujo D, Ravi V, Patel S, Benjamin R, Wargo J, Wistuba II, Somaiah N, Roland CL, Keung EZ, Solis L, Wang WL, Lazar AJ, Nassif EF. The immune landscape of undifferentiated pleomorphic sarcoma. Front Oncol 12:1008484, 2022. e-Pub 2022. PMID: 36313661.
19. Somaiah N, Conley AP, Parra ER, Lin H, Amini B, Solis Soto L, Salazar R, Barreto C, Chen H, Gite S, Haymaker C, Nassif EF, Bernatchez C, Mitra A, Livingston JA, Ravi V, Araujo DM, Benjamin R, Patel S, Zarzour MA, Sabir S, Lazar AJ, Wang WL, Daw NC, Zhou X, Roland CL, Cooper ZA, Rodriguez-Canales J, Futreal A, Soria JC, Wistuba II, Hwu P. Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial. Lancet Oncol 23(9):1156-1166, 2022. e-Pub 2022. PMID: 35934010.
20. Boyce-Fappiano D, Damron EP, Farooqi A, Mitra D, Conley AP, Somaiah N, Araujo DM, Livingston JA, Ratan R, Keung EZ, Roland CL, Guadagnolo BA, Bishop AJ. Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions. Adv Radiat Oncol 7(3):100913, 2022. e-Pub 2022. PMID: 35647398.
21. Patel RR, Lupo PJ, Bishop AJ, Lin PP, Delclos GL, Lazar AJ, Benjamin RS, Araujo DM. Synovial Sarcoma of the Hand and Foot: An Institutional Review. Am J Clin Oncol 44(7):361-368, 2021. e-Pub 2021. PMID: 33927134.
22. Parkes A, Wang WL, Patel S, Leung CH, Lin H, Conley AP, Somaiah N, Araujo DM, Zarzour M, Livingston JA, Ludwig J, Roland CL, Ravi V, Benjamin RS, Ratan R. Outcomes of systemic therapy in metastatic phyllodes tumor of the breast. Breast Cancer Res Treat 186(3):871-882, 2021. e-Pub 2021. PMID: 33575859.
23. Pollack SM, Somaiah N, Araujo DM, Druta M, Van Tine BA, Burgess MA, Chawla SP, Seetharam M, Okuno SH, Bohac C, Chen M, Yurasov S, Attia S. Clinical outcomes of patients with advanced synovial sarcoma or myxoid/round cell liposarcoma treated at major cancer centers in the United States. Cancer Med 9(13):4593-4602, 2020. e-Pub 2020. PMID: 32374488.
24. Chow W, Frankel P, Ruel C, Araujo DM, Milhem M, Okuno S, Hartner L, Undevia S, Staddon A. Results of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcoma. Cancer 126(1):105-111, 2020. e-Pub 2020. PMID: 31509242.
25. El Beanino M, Jupiter DC, Assi T, Rassy E, Lazar AJ, Araujo DM, Lin PP. Diagnostic Value of TLE1 in Synovial Sarcoma: A Systemic Review and Meta-Analysis. Sarcoma, 2020. e-Pub 2020.
26. Li J, Chang HM, Banchs J, Araujo DM, Hassan SA, Wagar EA, Yeh ETH, Meng QH. Detection of subclinical cardiotoxicity in sarcoma patients receiving continuous doxorubicin infusion or pre-treatment with dexrazoxane before bolus doxorubicin. Cardiooncology 6:1, 2020. e-Pub 2020. PMID: 32154027.
27. Parkes A, Urquiola E, Bhosale P, Lin H, Watson K, Wang WL, Feig B, Torres K, Roland CL, Conley AP, Zarzour M, Livingston JA, Ratan R, Ludwig J, Araujo DM, Ravi V, Benjamin RS, Patel S, Somaiah N. PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated Liposarcoma. Sarcoma 2020:8363986, 2020. e-Pub 2020. PMID: 32565716.
28. Joseph J, Nathenson MJ, Trinh VA, Malik K, Nowell E, Carter K, Weathers SP, Demetri GD, Araujo D, Conley AP. Guillain-Barre syndrome observed with adoptive transfer of lymphocytes genetically engineered with an NY-ESO-1 reactive T-cell receptor. J Immunother Cancer 7(1):296, 2019. e-Pub 2019. PMID: 31703609.
29. Ramachandran I, Lowther DE, Dryer-Minnerly R, Wang R, Fayngerts S, Nunez D, Betts G, Bath N, Tipping AJ, Melchiori L, Navenot JM, Glod J, Mackall CL, D'Angelo SP, Araujo DM, Chow WA, Demetri GD, Druta M, Van Tine BA, Grupp SA, Abdul Razak AR, Wilky B, Iyengar M, Trivedi T, Winkle EV, Chagin K, Amado R, Binder GK, Basu S. Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma. J Immunother Cancer 7(1):276, 2019. e-Pub 2019. PMID: 31651363.
30. Bishop AJ, Livingston JA, Araujo DM, Moon BS, Patel S, Wang WL, Lazar AJ, Roland CL, Guadagnolo BA. Extraskeletal Osteosarcomas: A Case Made for Combined Modality Local Therapy With Radiation and Surgery. Am J Clin Oncol 42(3):238-242, 2019. e-Pub 2019. PMID: 30614820.
31. Raut CP, Espat NJ, Maki RG, Araujo DM, Trent J, Williams TF, Purkayastha DD, DeMatteo RP. Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected Intermediate- or High-Risk Primary Gastrointestinal Stromal Tumor The PERSIST-5 Clinical Trial. JAMA Oncol 4(12):e184060, 2018. e-Pub 2018. PMID: 30383140.
32. McBride MJ, Pulice JL, Beird HC, Ingram DR, D'Avino AR, Shern JF, Charville GW, Hornick JL, Nakayama RT, Garcia-Rivera EM, Araujo DM, Wang WL, Tsai JW, Yeagley M, Wagner AJ, Futreal PA, Khan J, Lazar AJ, Kadoch C. The SS18-SSX Fusion Oncoprotein Hijacks BAF Complex Targeting and Function to Drive Synovial Sarcoma. Cancer Cell 33(6):1128-1141.e7, 2018. e-Pub 2018. PMID: 29861296.
33. Ikoma N, Araujo D, Roland CL. The Hereditary Paraganglioma-Pheochromocytoma Syndrome: No Time to Waste-Reply. JAMA Oncol 3(12):1740, 2017. e-Pub 2017. PMID: 28837712.
34. Furst M, Somogyi MB, Wong RW, Araujo D, Harper CA. TAMOXIFEN RETINOPATHY DURING TREATMENT OF AN INOPERABLE DESMOID TUMOR. Retin Cases Brief Rep. e-Pub 2017. PMID: 29227350.
35. Quintana R, Banchs J, Gupta R, Lin H, Raj S, Conley A, Ravi V, Araujo D, Benjamin RS, Patel S, Vadhan-Raj, S, Somaiah N. Early Evidence of cardiotoxicity and tumor response in patients with sarcomas after high cumulative dose doxorubicin given as a continuous infusion. Sarcoma 2017, 2017. e-Pub 2017.
36. Schvartsman G, Wagner MJ, Amini B, Zobniw CM, Trinh VA, Barbo AG, Lin HY, Wang WL, Conley AP, Ravi V, Araujo DM, Zarzour MA, Benjamin RS, Patel S, Somaiah N. Treatment patterns, efficacy and toxicity of regorafenib in gastrointestinal stromal tumour patients. Sci Rep 7(1):9519, 2017. e-Pub 2017. PMID: 28842575.
37. Wagner MJ, Gopalakrishnan V, Ravi V, Livingston JA, Conley AP, Araujo D, Somaiah N, Zarzour MA, Ratan R, Wang WL, Patel SR, Lazar A, Ludwig JA, Benjamin RS. Vincristine, Ifosfamide, and Doxorubicin for Initial Treatment of Ewing Sarcoma in Adults. The Oncologist. e-Pub 2017.
38. Kumar R, Duran C, Amini B, Araujo DM, Wang WL. Periosteal mesenchymal chondrosarcoma of the tibia with multifocal bone metastases: a case report. Skeletal Radiology 46(7), 2017. e-Pub 2017.
39. Gopalakrishnan V, Amini B, Wagner MJ, Nowell EN, Lazar AJ, Lin PP, Benjamin RS, Araujo DM. Synovial Sarcoma of the Head and Neck: A Single Institution Review. Sarcoma 2017:1-8, 2017. e-Pub 2017.
40. Barrott JJ, Kafchinski LA, Jin H, Potter JW, Kannan SD, Kennedy R, Mosbruger T, Wang WL, Tsai JW, Araujo DM, Liu T, Capecchi MR, Lazar AJ, Jones KB. Modeling synovial sarcoma metastasis in the mouse: PI3'-lipid signaling and inflammation. J Exp Med 12(213):2989-3005, 2016. e-Pub 2016.
41. Gupta R, Heshami N, Jay C, Ramesh N, Song J, Lei X, Rose EJ, Carter K, Araujo DM, Benjamin RS, Patel S, Nates JL, Ravi V. Predictors of survival in patients with sarcoma admitted to the intensive care unit. Clinical Sarcoma Research 6(12), 2016. e-Pub 2016.
42. Beaino ME, Araujo DM, Gopalakrishnan V, Lazar AJ, Lin PP. Prognosis of T1 synovial sarcoma depends upon surgery by oncologic surgeons. J Surg Oncol. e-Pub 2016. PMID: 27220538.
43. Lenihan DJ, Stevens PL, Massey M, Plana JC, Araujo DM, Fanale MA, Fayad LE, Fisch MJ, Yeh ET. The Utility of Point-of-Care Biomarkers to Detect Cardiotoxicity During Anthracycline Chemotherapy: A Feasibility Study. J Card Fail. e-Pub 2016. PMID: 27079675.
44. Fu S, Hou MM, Naing A, Janku F, Hess K, Zinner R, Subbiah V, Hong D, Wheler J, Piha-Paul S, Tsimberidou A, Karp D, Araujo D, Kee B, Hwu P, Wolff R, Kurzrock R, Meric-Bernstam F. Phase I study of Pazopanib and Vorinostat: a Therapeutic Approach for Inhibiting Mutant p53-Mediated Angiogenesis and Facilitating Mutant p53 Degradation. Annals of Oncology 26(5):1012-8, 2015. e-Pub 2015.
45. Pappo AS, Vassal G, Crowley JJ, Bolejack V, Hogendoorn PC, Chugh R, Ladanyi M, Grippo JF, Dall G, Staddon AP, Chawla SP, Maki RG, Araujo DM, Geoerger B, Ganjoo K, Marina N, Blay JY, Schuetze SM, Chow WA, Helman LJ. A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance for Research Through Collaboration study. Cancer 120(16):2448-56, 2014. e-Pub 2014. PMID: 24797726.
46. Bednarski BK, Araujo DM, Yi M, Torres KE, Lazar A, Trent JC, Cormier JN, Pisters PW, Lev DC, Pollock RE, Feig BW, Hunt KK. Analysis of Prognostic Factors Impacting Oncologic Outcomes After Neoadjuvant Tyrosine Kinase Inhibitor Therapy for Gastrointestinal Stromal Tumors. Ann Surg Oncol 21(8):2499-505, 2014. e-Pub 2014. PMID: 24639192.
47. Conter HJ, Gopalakrishnan V, Ravi V, Ater JL, Patel S, Araujo DM. Adult versus Pediatric Neuroblastoma: The M.D. Anderson Cancer Center Experience. Sarcoma 2014:375151, 2014. e-Pub 2014. PMID: 25024639.
48. Dumont SN, Araujo DM, Munsell MF, Salganick JA, Dumont AG, Raymond KA, Linassier C, Patel S, Benjamin RS, Trent JC. Management and outcome of 239 adolescent and adult rhabdomyosarcoma patients. Cancer Med 2(4):553-63, 2013. e-Pub 2013. PMID: 24156028.
49. Park MS, Ravi V, Conley A, Patel SR, Trent JC, Lev DC, Lazar AJ, Wang WL, Benjamin RS, Araujo DM. The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis. Clinical Sarcoma Research, 2013. e-Pub 2013.
50. Hensley ML, Wathen JK, Maki RG, Araujo DM, Sutton G, Priebat DA, George S, Soslow RA, Baker LH. Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: Results of a phase 2 trial (SARC 005). Cancer 119(8):1555-61, 2013. e-Pub 2013. PMID: 23335221.
51. Demicco EG, Park MS, Araujo DM, Fox PS, Bassett RL, Pollock RE, Lazar AJ, Wang WL. Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model. Modern Pathology 25(9):1298-306, 2012. e-Pub 2012.
52. Katz D, Boonsirikamchai P, Choi H, Lazar AJ, Wang WW, Xiao L, Park MS, Ravi V, Benjamin RS, Araujo DM. Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma. Clinical Sarcoma Research 2(1):2, 2012. e-Pub 2012.
53. Wang WL, Katz D, Araujo DM, Ravi V, Ludwig JA, Trent JC, Patel SR, Lin PP, Guadagnolo A, Lòpez-Terrada D, Dei Tos AP, Lewis VO, Lev D, Pollock RE, Zagars GK, Benjamin RS, Madewell JE, Lazar AJ. Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy. Clin Sarcoma Res 2(1):25, 2012. e-Pub 2012. PMID: 23272660.
54. Park MS, Patel SR, Ludwig JA, Trent JC, Conrad CA, Lazar AJ, Wang WL, Boonsirikamchai P, Choi H, Wang X, Benjamin RS, Araujo DM. Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer, 2011. e-Pub 2011. PMID: 21480200.
55. Yang J, Yang D, Sun Y, Sun B, Wang G, Trent J, Araujo D, Chen K, Zhang W. Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma. Cancer 117(21):4925-38, 2011. e-Pub 2011.
56. Guadagnolo BA, Zagars GK, Araujo D, Ravi V, Shellenberger TD, Sturgis EM. Outcomes after defininitive treatment of cutaneous angiosarcoma of the face and scalp. Head Neck 33(5):661-7, 2011. e-Pub 2011.
57. Shinder R, Jackson TL, Araujo D, Prieto VG, Guadagnolo BA, Esmaeli B. Preoperative Radiation Therapy in the Management of Recurrent Orbital Hemangiopericytoma. Ophthal Plast Reconstr Surg, 2011. e-Pub 2011. PMID: 21242853.
58. Pandurengan RK, Dumont AG, Araujo DM, Ludwig JA, Ravi V, Patel S, Garber J, Benjamin RS, Strom SS, Trent JC. Survival of Patients with Multiple Primary Malignancies: A Study of 783 Patients with Gastrointestinal Stromal Tumor. Annals of Oncology 21(10):2107-11, 2010. e-Pub 2010. PMID: 20348145.
59. Vadhan-Raj S, Trent J, Patel S, Zhou X, Johnson MM, Araujo D, Ludwig J, O'Roark S, Gillenwater AM, Bueso-Ramos C, El-Naggar AK, Benjamin RS. Single-Dose Palifermin Prevents Severe Oral Mucositis During Multicycle Chemotherapy in Patients with Cancer. Annals of Internal Medicine 153(6):358-367, 2010. e-Pub 2010.
60. Trent JC, MD, PhD, Patel SS, Zhang J, PhD, Araujo D, MD, Plana J, MD, Lenihan DJ, MD, Fan D, PhD, Patel SR, MD, Benjamin RS, MD, Y Khakoo AA, MD. Rare Incidence of Congestive Heart Failure in Gastrointestinal Stromal Tumor and Other Sarcoma Patients Receiving Imatinib Mesylate. Cancer 116(1):184-192, 2010. e-Pub 2010. PMID: 19885836.
61. Trent JC, Patel SS, Zhang J, Araujo DM, Plana JC, Lenihan DJ, Fan D, Patel SR, Benjamin RS, Khakoo AY. Rare incidence of congestive heart failure in gastrointestinal stromal tumor and other sarcoma patients receiving imatinib mesylate. Cancer 116:184-192, 2010. e-Pub 2010.
62. Wang WL, Mayordomo E, Czerniak BA, Abruzzo LV, Cin PD, Araujo DM, Lev DC, López-Terrada D, Lazar AJ. Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcoma. Mod Pathol 21(11):1303-10, 2008. e-Pub 2008. PMID: 18587326.
63. Armistead PM, Salganick J, Roh JS, Steinert DM, Patel S, Munsell M, El-Naggar AK, Benjamin RS, Zhang W, Trent JC. Expression of receptor tyrosine kinases and apoptotic molecules in rhabdomyosarcoma: correlation with overall survival in 105 patients. Cancer 110(10):2293-303, 2007. e-Pub 2007. PMID: 17896786.
64. McAuliffe JC, Lazar AJ, Yang D, Steinert DM, Qiao W, Thall PF, Raymond AK, Benjamin RS, Trent JC. Association of intratumoral vascular endothelial growth factor expression and clinical outcome for patients with gastrointestinal stromal tumors treated with imatinib mesylate. Clin Cancer Res 13(22 Pt 1):6727-34, 2007. e-Pub 2007. PMID: 18006774.
65. Chirieac LR, Trent JC, Steinert DM, Choi H, Yang Y, Zhang J, Patel SR, Benjamin RS, Raymond AK. Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate. Cancer 107(9):2237-44, 2006. e-Pub 2006. PMID: 16998931.
66. Steinert DM, Oyarzo M, Wang X, Choi H, Thall PF, Medeiros LJ, Raymond AK, Benjamin RS, Zhang W, Trent JC. Expression of Bcl-2 in gastrointestinal stromal tumors: correlation with progression-free survival in 81 patients treated with imatinib mesylate. Cancer 106(7):1617-23, 2006. e-Pub 2006. PMID: 16518826.

Invited Articles

1. Park MS, Ravi V, Araujo DM. Inhibiting the VEGF-VEGFR Pathway in Angiosarcoma, Epithelioid Hemangioendothelioma, and Hemangiopericytoma/Solitary Fibrous Tumor. Current Opinion in Oncology 22(4):351-355, 2010. e-Pub 2010.
2. Park MS, Araujo DM. New insights into the hemangiopericytoma/solitary fibrous tumor spectrum of tumors. Current Opinion in Oncology 21(4):327-31, 2009. e-Pub 2009. PMID: 19444101.
3. Steinert DM, Patel SR. Recent studies in novel therapy for metastatic sarcomas. Hematol Oncol Clin North Am 19(3):573-90, viii, 2005. e-Pub 2005. PMID: 15939198.
4. Steinert DM, Blakely LJ, Salganick J, Trent JC. Molecular targets in therapy for human soft-tissue and bone sarcomas. Curr Oncol Rep 5(4):295-303, 2003. e-Pub 2003. PMID: 12781071.

Other Articles

1. El Beaino M, Jupiter DC, Assi T, Rassy E, Lazar AJ, Araujo DM, Lin PP Diagnostic Value of TLE1 in Synovial Sarcoma: A Systematic Review and Meta-Analysis. Sarcoma 2020:7192347, 2020. PMID: 32322158.
2. El Beaino M, Araujo DM, Lazar AJ, Lin PP Synovial Sarcoma: Advances in Diagnosis and Treatment Identification of New Biologic Targets to Improve Multimodal Therapy. Ann Surg Oncol 24(8):2145-2154, 2017. PMID: 28397189.
3. Subbiah V, Westin SN, Wang K, Araujo D, Wang WL, Miller VA, Ross JS, Stephens PJ, Palmer GA, Ali SM Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein. J Hematol Oncol 14(7(1)):8, 2014. PMID: 24422672.
4. Shome D, Trent J, Espandar L, Hatef E, Araujo DM, Song CD, Kim SK, Esmaeli B Ulcerative keratitis in gastrointestinal stromal tumor patients treated with perifosine. Ophthalmology 115(3):483-7, 2008. PMID: 18201764.
5. Steinert DM, McAuliffe JC, Trent JC Imatinib mesylate in the treatment of gastrointestinal stromal tumour. Expert Opin Pharmacother 6(1):105-13, 2005. PMID: 15709888.
6. D'Amato G, Steinert DM, McAuliffe JC, Trent JC Update on the biology and therapy of gastrointestinal stromal tumors. Cancer Control 12(1):44-56, 2005. PMID: 15668652.

Abstracts

1. Wermke M, Alsdorf W, Araujo DM, Busse A, Chatterjee M, Hernandez-Aya LF, Hilf N, Wilhelm Holderried TA, Jazaeri AA, Kursunel M, Mayer-Mokler A, Mendrzyk R, Mohamed A, Patel SP, Reshef R, Tsimberidou AM, Walter S, Weinschenk T, Luke JJ, Britten C, University Hospital Carl Gustav Carus, Dresden, Germany, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, The University of Texas MD Anderson Cancer Center, Houston, TX, Charite Medical University Hospital, Berlin, Germany, University Hospital Wuerzburg, Wuerzburg, Germany, University of Miami, Miami, FL, Immatics N.V., Tuebingen, Germany, University Hospital Bonn, Bonn, Germany, University of Colorado Cancer Center, Aurora, CO, Columbia University, New York City, NY, University of Texas MD Anderson Cancer Center, Houston, TX, University of Pittsburgh Medical Center, Pittsburgh, PA. Phase 1 clinical update of IMA203, an autologous TCR-T targeting PRAME in patients with PD1 refractory metastatic melanoma. ASCO 2025 Annual Meeting, 2025. e-Pub 2025.
2. Raj R, Vilson R, Joseph C, Lin H, Munnangi P, Thirasastr P, Nakazawa M, Torres K, Araujo D, Benjamin RS, Conley AP, Livingston JA, Ludwig J, Patel S, Ratan R, Ravi V, Zarzour M, Nassif E, Somaiah N. NF1 and non-NF1 associated Malignant Peripheral Nerve Sheath Tumors (MPNST): the UT MD Anderson (MDACC) experience. ASCO 2025 Annual Meeting, 2025. e-Pub 2025.
3. Soewito S, Lin HY, Zoghbi M, Pan C, Young P, Araujo DM, Conley AP, Livingston J, Ludwig JA, Nakazawa M, Ratan R, Ravi V, Somaiah N, Zarzour MA, Patel S, Meyer LA, Soliman PT, Lyu H, Nassif Haddad EF, Denu RA, University of Texas Health Science Center at Houston, Houston, TX, The University of Texas MD Anderson Cancer Center, Houston, Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Doxorubicin-based chemotherapy vs gemcitabine/docetaxel in uterine leiomyosarcoma (ULMS). ASCO 2025 Annual Meeting, 2025. e-Pub 2025.
4. D’Angelo SP, Druta M, Van Tine B, Schuetze SM, Blay J, Morales CV, Forcade E, Ganjoo KN, Le Cesne A, Strauss SJ, Araujo DM, Choy E, Dupont C, Williams D, Bai J, Fernandes L, Van Winkle E, O’Connor A, Norry E. Long-term survival of patients with advanced/metastatic synovial sarcoma or myxoid/round cell liposarcoma who received afamitresgene autoleucel T-cell receptor T-cell therapy in SPEARHEAD-1. SITC 2025 Annual Meeting, 2025. e-Pub 2025.
5. D’Angelo SP, Druta M, Van Tine B, Schuetze SM, Blay J, Morales CV, Forcade E, Ganjoo KN, Le Cesne A, Strauss SJ, Araujo DM, Choy E, Dupont C, Williams D, Bai J, Fernandes L, Van Winkle E, O’Connor A, Norry E. Long-Term Survival of Patients With Advanced/Metastatic Synovial Sarcoma or Myxoid/Round Cell Liposarcoma Who Received the T-Cell Receptor T-Cell Therapy, Afamitresgene Autoleucel, in the Phase 2 SPEARHEAD-1 Trial. TANDEM 2025 Annual Meeting, 2025. e-Pub 2025.
6. Araujo DM, Wermke M, Alsdorf W, Busse A, Aya LH, Hilf N, Holderried TA, Jazaeri AA, Letizia M, Mayer-Mokler A, Mendrzyk R, Mohamed A, Pankov D, Patel S, Tsimberidou A, Walter S, Weinschenk T, Luke JJ, Britten CM. Enhanced pharmacology data of next-generation IMA203CD8 TCR-T monotherapy targeting PRAME. SITC 2024 Annual Meeting, 2024. e-Pub 2024.
7. Brunk F, Patino RB, Wagner C, Porichis F, Kursunel AM, Sun J, Diab A, Araujo DM, Ott PA, Smithy J, Hilf N, Krishna D, Weiss B, Mayer-Mokler A, Lukacs C, Pozo K, Guey L, Mori S, Britten CM. Combination of a TCR-engineered Autologous PRAME-targeting T Cell Therapy with a PRAME-encoding mRNA for the Treatment of Solid Tumors. SITC 2024 Annual Meeting, 2024. e-Pub 2024.
8. Kushnarev V, Shevkoplias A, Kryukov K, Bagaev A, Lennerz JK, Kotlov N, Cote GM, Yalamanchili S, Somaiah N, Araujo D, Thomas J, Conley A, Rosenbaum E, Ravi V, Cherneyshov K, Chawla SP. Identifying Novel Targets for Antibody-drug conjugates in Sarcomas Using RNA Sequencing. SITC 2024 Annual Meeting, 2024. e-Pub 2024.
9. Ravi N, Nakazawa M, Livingston J, Ratan R, Zarzour MA, Conley AP, Araujo D, Ravi V, Somaiah N, Patel S, Nassif Haddad EF. Incidence of germline genetic mutations identified on standard-of-care genomic sequencing for advanced sarcomas. CTOS 2024 Annual Meeting, 2024. e-Pub 2024.
10. Gingrich A, Beird H, Lazcano R, Denu RA, Truong DD, Nakazawa MS, Ratan R, Livingston J, Zarzour A, Conley AP, Somaiah N, Araujo D, Patel SS, Ravi V, Roland C, Futreal P, Lazar A, Keung E, Haddad EN. Immune Classes of Leiomyosarcoma Driven by B Cell Infiltrate and CTLA4 Expression. CTOS 2024 Annual Meeting, 2024. e-Pub 2024.
11. Wagner MJ, Lunt C, Araujo D, Blay J, Druta M, Attia S, Valverde Morales CM, Ganjoo KN, Schuetze SM, Winkle EV, Bayer P, Bai J, Bestul D, Desai V, Yule M, Williams D, Norry E, Van Tine BA. Impact of Afami-Cel on the Health State of Patients with Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma: Cohort 1 of Spearhead-1. CTOS 2024 Annual Meeting, 2024. e-Pub 2024.
12. Arifin AJ, Bishop AJ, Mitra D, Araujo DM, Nassif Haddad EF, Ratan R, Livingston J, Lewis VO, Lin PP, Moon BS, Keung E, Roland CL, Scally C, Guadagnolo B, Farooqi AS. Addressing the Primary Site in Patients with Metastatic Soft Tissue Sarcoma: Is There a role for a Combined Modality Treatment?. CTOS 2024 Annual Meeting, 2024. e-Pub 2024.
13. Livingston J, Gill JB, Conley AP, Somaiah N, Araujo D, Ratan R, Ravi V, Zarzour A, Benjamin R, Patel S, Daw N, Harrison DJ, Gorlick R, Otto T, Lin H, Wang W, Amini B, Kleinerman E, Gordon N. A Phase 1/2 Trial of Gemcitabine, Docetaxel, and Hydroxychloroquine in Advanced Metastatic Osteosarcoma: Final Results. CTOS 2024 Annual Meeting, 2024. e-Pub 2024.
14. Arifin AJ, Bishop AJ, Mitra D, Araujo DM, Nassif Haddad EF, Ratan R, Livingston J, Lewis VO, Lin PP, Moon BS, Keung E, Roland CL, Scally C, Guadagnolo B, Farooqi AS. Outcomes following combined modality treatment to the primary site in patients with metastatic soft tissue sarcoma. ASTRO 2024 Annual Meeting, 2024. e-Pub 2024.
15. Livingston A, Gill J, Conley A, Somaiah N, Araujo D, Ratan R, Ravi V, Zarzour A, Benjamin R, Patel S, Daw NC, Harrison D, Gorlick R, Otto T, Lin H, Wang W, Amini B, Kleinerman E, Gordon N. A Phase 1/2 trial of Gemcitabine/Docetaxel and Hydroxychloroquine in Advanced Metastatic Osteosarcoma. ESMO 2024 Annual Meeting, 2024. e-Pub 2024.
16. Zirov K, Voropaeva M, Aukhadieva A, Makarova A, Shevkoplias A, Novokreshchenova A, Dubrovskaya A, Lebedev D, Yong ST, Brown J, Chawla S, Cote GM, Livingston JA, Subbiah V, Araujo DM, Bagaev A, Bedniagin L, Conley A. Genomic and transcriptomic analysis of chondrosarcomas to explore new potential treatment options. ESMO 2024 Annual Meeting, 2024. e-Pub 2024.
17. Elise Nassif Haddad, Jason T. Smith, Davis R. Ingram, Khalida M. Wani, Michael S. Nakazawa, Ravin Ratan, John Andrew Livingston, Anthony Paul Conley, Maria Alejandra Zarzour, Neeta Somaiah, Dejka Araujo, Vinod Ravi, Shreyaskumar Patel, Emily Z. Keung, Wei-Lien Wang, Alexander Lazar. Clear Cell Sarcomas (CCS) Express Gp 100, A Novel Immune Target For A Bispecific T Cell Engager. ESMO 2024 Annual Meeting, 2024. e-Pub 2024.
18. Wagner M, Lunt C, Araujo D, Blay J, Druta M, Attia S, Morales CM, Ganjoo K, Schuetze S, Winkle E, Bayer P, Bai J, Bestul D, Desai V, MYule, Williams D, Norry E, Van Tine B. Health state impacts of Afamitresgene Autoleucel therapy (Afami-cel) in Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma: SPEARHEAD-1 Cohort 1 analysis. ESMO 2024 Annual Meeting, 2024. e-Pub 2024.
19. Alicia A. Gingrich, Hannah Beird, Rossana Lazcano Segura, Ryan Denu, Michael Nakazawa, Ravin Ratan, J. Andrew Livingston, Maria Alejandra Zarzour, Anthony Paul Conley, Neeta Somaiah, Dejka M. Araujo, S Shreyaskumar Patel, Christina Lynn Roland, Andrew Futreal, Alexander J. Lazar, Emily Zhi-Yun Keung, Elise F Nassif Haddad, Rare Tumor Initiative Team, Patient Mosaic Team; The University of Texas MD Anderson Cancer Center, Houston, TX, Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX. Immune Infiltrate Analysis Reveals Distinct Immune Class for Leiomyosarcomas. ASCO 2024 Annual Meeting, 2024. e-Pub 2024.
20. Munnangi P, King BL, Chiang Y, Conley AP, Araujo DM, Livingston J, Ludwig JA, Nakazawa M, Nassif Haddad EF, Ravi V, Ratan R, Zarzour MA, Patel S, Torres KE, Somaiah N, Texas A&M School of Engineering Medicine, Houston, TX, The University of Texas MD Anderson Cancer Center, Houston TX, Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, The University of Texas MD Anderson Cancer Center Hematology/Oncology Fellowship, Houston, TX, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Systemic therapy in NF-1 associated malignant peripheral nerve sheath tumors (MPNST). ASCO 2024 Annual Meeting, 2024. e-Pub 2024.
21. Nassif EF, Beird H, Mitra A, Liu B, McBride K, Wang W, Ingram D, Wani K, Keung EZ, Initiative Team RT, Team PM, Zarzour A, Conley A, Araujo D, Livingston J, Ratan R, Patel S, Ravi V, Benjamin R, Lazar AJ, Roland CL, Futreal P, Somaiah N. Histology Specific Intratumoral B-Cell Biology in Alveolar Soft-Part Sarcomas (ASPS) in Response to Durvalumab-Tremelimumab (D-T). CTOS 2023 Annual Meeting, 2023. e-Pub 2023.
22. Denu RA, Joseph CP, Urquiola ES, Byrd PS, Ratan R, Zarzour MA, Conley AP, Araujo D. Clinico-Genomic Analysis of KIT/PDGFRA/SDH Wild-Type Gatrointestinal Stromal Tumors Identifies Potential Driver Mutations. CTOS 2023 Annual Meeting, 2023. e-Pub 2023.
23. Cock LD, Wozniak A, Zhu M, Vanleeuw U, Sciot R, Wang G, Beird H, Araujo D, Schoffski P. Efficacy and Toxicity of Verteporfin in Combination With Pazopanib Tested in a Patient-Derived Synovial Sarcoma Xenograft. CTOS 2023 Annual Meeting, 2023. e-Pub 2023.
24. Livingston J, Cloutier J, Conley AP, Gorlick R, Benjamin RS, Posey K, Nassif E, Zarzour M, Araujo D, Ratan R, Ravi V, Somaiah N, Lin H, Leung CH, Lazar AJ, Lewis VO, Lin P, Amini B, Valenzuela RF, Patel S, Wang W. Chemotherapy and Prognostic Significance of Extent of Dedifferentiation in Dedifferentiated Parosteal Osteosarcoma. CTOS 2023 Annual Meeting, 2023. e-Pub 2023.
25. Van Tine BA, Ganjoo KN, Blay J, Valverde C, Araujo DM, Abdul Razak AR, Cesne AL, Schuetze SM, Wagner MJ, Attia S, Forcade E, Mihaela, Pollack S, Bai J, Bayer P, Winkle EV, Norry E, Lunt C, Williams D, D'Angelo SP. Outcomes Of Patients With Advanced Synovial Sarcoma Treated With Afamitresgene Autoleucel ("AFAMI-CEL"). CTOS 2023 Annual Meeting, 2023. e-Pub 2023.
26. Torres MB, Leung CH, Keung E, Feng C, Beird H, Zarzour A, Scally C, Hunt K, Conley A, Bishop A, Guadagnolo B, Farooqi A, Mitra D, Araujo D, Livingston A, Ratan R, Patel S, Ravi V, Lazar A, Roland CL, Somaiah N, Nassif EF. Dedifferentiated Liposarcomas Treated With Immune Checkpoint Blockade: The MD Anderson Experience. CTOS 2023 Annual Meeting, 2023. e-Pub 2023.
27. Gingrich A, Beird H, Chu R, Traweek R, Cope B, Keung EZ, Scally CP, Hunt KK, Torres KE, Roland CL, Initiative Team SPT, Team PM, Futreal P, Bishop A, Guadagnolo B, Mitra D, Farooqi A, Araujo D, Alejandra Zarzour AM, Livingston J, Conley A, Patel S, Ravi V, Somaiah N, Lazar AJ, Ratan R, Nassif EF. Leiomyosarcoma intratumoral macrophage infiltrates are associated with distinct clinical and genomic presentations. CTOS 2023 Annual Meeting, 2023. e-Pub 2023.
28. Patel RR, Bishop AJ, Lazar AJ, Lin PP, Vaporciyan AA, Benjamin RS, Patel SR, Ludwig JA, Ravi V, Araujo DM. An Institutional Review of Patients Presenting with Localized Primary Intrathoracic Synovial Sarcoma. CPRIT 2023 Innovations IV in Cancer Prevention and Research Conference, 2023. e-Pub 2023.
29. Thirasastr P, Lin HY, Nassif EF, Wang W, Araujo DM, Benjamin RS, Conley AP, Livingston JA, Ludwig JA, Patel S, Ratan R, Ravi V, Zarzour MA, Zhou X, Somaiah N. Clinical implications of recurring mutations in myxoid liposarcoma (MLS). ASCO 2023 Annual Meeting, 2023. e-Pub 2023.
30. Van Tine BA, Ganjoo KN, Blay J, Valverde C, Araujo DM, Abdul Razak AR, Cesne AL, Schuetze S, Wagner MJ, Attia S, Forcade E, Druta M, Pollack S, Bai J, Bayer P, Winkle EV, Norry E, McAlpine C, Williams D, D'Angelo SP. The SPEARHEAD-1 trial of afamitresgene autoleucel (afami-cel [formerly ADP-A2M4]): Analysis of overall survival in advanced synovial sarcoma. ASCO 2023 Annual Meeting, 2023. e-Pub 2023.
31. D'Angelo SP, Ganjoo KN, Blay J, Valverde C, Araujo DM, Abdul Razak AR, Cesne AL, Schuetze S, Wagner MJ, Attia S, Forcade E, Druta M, Pollack S, Bai J, Lunt C, Sun A, Yule M, McAlpine C, Williams D, Van Tine BA. The SPEARHEAD-1 trial of afamitresgene autoleucel (afami-cel [formerly ADP-A2M4]): Pooled analysis of cytokine release syndrome across cohorts in patients with advanced synovial sarcoma. ASCO 2023 Annual Meeting, 2023. e-Pub 2023.
32. Nardo M, Gouda MA, Ahmed J, Noia Barreto CM, Nelson BE, Araujo DM, Blumenschein GR, Tsimberidou AM, Piha-Paul SA, Dumbrava EE, Hong DS. Predictors of survival outcomes in patients (pts) with advanced solid tumors treated with cellular therapies in early clinical trials. ASCO 2023 Annual Meeting, 2023. e-Pub 2023.
33. Araujo DM, Ladle BH, He K, Powers B, McGillivray A, Mitrica I, Liu W, Patel N, D'Angelo SP. ZENYTH-ESO: Master protocol to assess the safety and recommended phase II dose of next generation NY-ESO-1-specific TCR T-cells in HLA-A*02 patients with synovial sarcoma and myxoid/round cell liposarcoma [Substudy 3, GSK4427296]. ASCO 2022 Annual Meeting, 2022. e-Pub 2022.
34. Somaiah N, Conley AP, Lin HY, Amini B, Sabir SH, Araujo DM, Benjamin RS, Livingston JA, Patel S, Ratan R, Ravi V, Zarzour MA, W-L W, Tate T, Roland CL, Daw NC, Futreal A, Lazar AJ, Wistuba II, Hwu P. A phase II multi-arm study of durvalumab and tremelimumab for advanced or metastatic sarcomas. ASCO 2020 Annual Meeting, 2020. e-Pub 2020.
35. Subramaniam A, Zheng J, Yalamanchili S, Conley AP, Ratan R, Somaiah N, Livingston A, Zarzour MA, Araujo DM, Benjamin RS, Patel S, Ravi V. Modulation of YAP/TAZ by statins to improve survival in epithelioid hemangioendothelioma (EHE). ASCO 2020 Annual Meeting, 2020. e-Pub 2020.
36. Araujo DM, Druta M, Agulnik M, D'Angelo SP, J-Y B, Strauss SJ, Valverde C, Razak ARA, Van Winkle E, Trivedi T, Biswas S, Williams D, Norry E. SPEARHEAD-1: A phase II trial of ADP-A2M4 SPEAR T cells in patients with advanced synovial sarcoma or myxoid/round cell liposarcoma. ASCO 2020 Annual Meeting, 2020. e-Pub 2020.

Book Chapters

1. Steinert DM, JC: T. Gastrointestinal stromal tumors. In: Ajani JA, Curley SA, Janjan NA, Lynch PM Gastrointestinal Cancer. M.D. Anderson Cancer Care Series. Springer Science + Business Media, Inc, 2005.

Letters to the Editor

1. Slade, M, Araujo, DM, Du, M, Parikh, B, Anderson, N, Van Tine, BA, Ghobadi, A. False-positive human immunodeficiency virus nuclear acid amplification technique testing following therapy with transgenic T cell receptor cellular therapy for synovial sarcoma. Bone marrow transplantation 59: 1190-1192, 2024.